Biological implications of glycosaminoglycan interactions with haemopoietic cytokines

Immunology and Cell Biology

Volumn 86, Issue 7, 2008, Pages 598-607

  Coombe, Deirdre R ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

Cytokine; Glycosaminoglycan; Haemopoiesis; Heparan sulphate; Heparin; Interleukin

Indexed keywords

CYTOKINE; FIBROBLAST GROWTH FACTOR; GLYCOSAMINOGLYCAN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPARAN SULFATE; HEPARIN; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6;

ALPHA HELIX; CELL PROLIFERATION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; NONHUMAN; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; FIBROBLAST GROWTH FACTORS; GLYCOSAMINOGLYCANS; HEMATOPOIESIS; HEPARIN; HUMANS; PROTEIN BINDING; PROTEOGLYCANS; RECEPTORS, FIBROBLAST GROWTH FACTOR;

EID: 53249151669     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2008.49     Document Type: Review

References (72)

1. Coombe DR, Kett WC. Heparan sulfate-protein interactions: therapeutic potential through structure-function insights. Cell Mol Life Sci 2005; 62: 410-424.
2. Linhardt RJ. Claude S. Hudson award address in carbohydrate chemistry. Heparin: structure and activity. J Med Chem 2003; 46: 2551-2564.
3. Kreuger J, Salmivirta M, Sturiale L, Gimenez-Gallego G, Lindahl U. Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. J Biol Chem 2001; 276: 30744-30752.
4. Allen BL, Filla MS, Rapraeger AC. Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition. J Cell Biol 2001; 155: 845-858.
5. Allen BL, Rapraeger AC. Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly. J Cell Biol 2003; 163: 637-648.
6. Kreuger J, Spillmann D, Li JP, Lindahl U. Interactions between heparan sulfate and proteins: the concept of specificity. J Cell Biol 2006; 174: 323-327.
7. Mulloy B, Forster MJ. Application of drug discovery software to the identification of heparin-binding sites on protein surfaces: A computational survey of the 4-helix cytokines. Mol Sim 2008; 34: 481-489.
8. Mulloy B, Rider CC. Cytokines and proteoglycans: an introductory overview. Biochem Soc Trans 2006; 34: 409-413.
9. Pellegrini L, Burke DF, von Delft F, Mulloy B, Blundell TL. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 2000; 407: 1029-1034.
10. Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 2000; 6: 743-750.
11. Canales A, Lozano R, Lopez-Mendez B, Angulo J, Ojeda R, Nieto PM et al. Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue. FEBS J 2006; 273: 4716-4727.
12. Harmer NJ, Robinson CJ, Adam LE, Ilag LL, Robinson CV, Gallagher JT et al. Multimers of the fibroblast growth factor (FGF)-FGF receptor-saccharide complex are formed on long oligomers of heparin. Biochem J 2006; 393: 741-748.
13. Jastrebova N, Vanwildemeersch M, Rapraeger AC, Gimenez-Gallego G, Lindahl U, Spillmann D. Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors. J Biol Chem 2006; 281: 26884-26892.
14. Delehedde M, Lyon M, Gallagher JT, Rudland PS, Fernig DG. Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts. Biochem J 2002; 366: 235-244.
15. Mohammadi M, Olsen SK, Goetz R. A protein canyon in the FGF-FGF receptor dimer selects from an a la carte menu of heparan sulfate motifs. Curr Opin Struct Biol 2005; 15: 506-516.
16. Harmer NJ. Insights into the role of heparan sulphate in fibroblast growth factor signalling. Biochem Soc Trans 2006; 34: 442-445.
17. Dexter TM, Spooncer E. Growth and differentiation in the hemopoietic system. Annu Rev Cell Biol 1987; 3: 423-441.
18. Roberts R, Gallagher J, Spooncer E, Allen TD, Bloomfield F, Dexter TM. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 1988; 332: 376-378.
19. de Wynter E, Allen T, Coutinho L, Flavell D, Flavell SU, Dexter TM. Localisation of granulocyte macrophage colony-stimulating factor in human long-term bone marrow cultures. Biological and immunocytochemical characterisation. J Cell Sci 1993; 106: 761-769.
20. Coombe DR. The role of stromal cell heparan sulphate in regulating haemopoiesis. Leuk Lymphoma 1996; 21: 399-406.
21. Bruno E, Luikart SD, Long MW, Hoffman R. Marrow-derived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines. Exp Hematol 1995; 23: 1212-1217.
22. Gupta P, Oegema Jr TR, Brazil JJ, Dudek AZ, Slungaard A, Verfaillie CM. Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche. Blood 1998; 92: 4641-4651.
23. Gupta P, Oegema Jr TR, Brazil JJ, Dudek AZ, Slungaard A, Verfaillie CM. Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins. Blood 2000; 95: 147-155.
24. McClure BJ, Hercus TR, Cambareri BA, Woodcock JM, Bagley CJ, Howlett GJ et al. Molecular assembly of the ternary granulocyte-macrophage colony-stimulating factor receptor complex. Blood 2003; 101: 1308-1315.
25. Dao MA, Creer MH, Nolta JA, Verfaillie CM. Biology of umbilical cord blood progenitors in bone marrow niches. Blood 2007; 110: 74-81.
26. Borojevic R, Carvalho MA, Correa-Junior JD, Arcanjo K, Gomes L, Joazeiro PP et al. Stroma-mediated granulocyte-macrophage colony-stimulating factor (GM-CSF) control of myelopoiesis: spatial organisation of intercellular interactions. Cell Tissue Res 2003; 313: 55-62.
27. Coombe DR, Stevenson SM, Kinnear BF, Gandhi NS, Mancera RL, Osmond RI et al. Platelet endothelial cell adhesion molecule 1 (PECAM-1) and its interactions with glycosaminoglycans: 2. biochemical analyses. Biochemistry 2008; 47: 4863-4875.
28. Wettreich A, Sebollela A, Carvalho MA, Azevedo SP, Borojevic R, Ferreira ST et al. Acidic pH modulates the interaction between human granulocyte-macrophage colony-stimulating factor and glycosaminoglycans. J Biol Chem 1999; 274: 31468-31475.
29. Sebollela A, Cagliari TC, Limaverde GS, Chapeaurouge A, Sorgine MH, Coelho-Sampaio T et al. Heparin-binding sites in granulocyte-macrophage colony-stimulating factor. Localization and regulation by histidine ionization. J Biol Chem 2005; 280: 31949-31956.
30. Hercus TR, Cambareri B, Dottore M, Woodcock J, Bagley CJ, Vadas MA et al. Identification of residues in the first and fourth helices of human granulocyte-macrophage colony-stimulating factor involved in biologic activity and in binding to the alpha- and beta-chains of its receptor. Blood 1994; 83: 3500-3508.
31. Modrowski D, Lomri A, Marie PJ. Glycosaminoglycans bind granulocyte-macrophage colony-stimulating factor and modulate its mitogenic activity and signaling in human osteoblastic cells. J Cell Physiol 1998; 177: 187-195.
32. Modrowski D, Basle M, Lomri A, Marie PJ. Syndecan-2 is involved in the mitogenic activity and signaling of granulocyte-macrophage colony-stimulating factor in osteoblasts. J Biol Chem 2000; 275: 9178-9185.
33. Feng Y, Klein BK, McWherter CA. Three-dimensional solution structure and backbone dynamics of a variant of human interleukin-3. J Mol Biol 1996; 259: 524-541.
34. Bagley CJ, Phillips J, Cambareri B, Vadas MA, Lopez AF. A discontinuous eight-amino acid epitope in human interleukin-3 binds the alpha-chain of its receptor. J Biol Chem 1996; 271: 31922-31928.
35. Alvarez-Silva M, Borojevic R. GM-CSF and IL-3 activities in schistosomal liver granulomas are controlled by stroma-associated heparan sulfate proteoglycans. J Leukoc Biol 1996; 59: 435-441.
36. Kimura K, Matsubara H, Sogoh S, Kita Y, Sakata T, Nishitani Y et al. Role of glycosaminoglycans in the regulation of T cell proliferation induced by thymic stroma-derived T cell growth factor. J Immunol 1991; 146: 2618-2624.
37. Cornelis S, Plaetinck G, Devos R, Van der Heyden J, Tavernier J, Sanderson CJ et al. Detailed analysis of the IL-5-IL-5R alpha interaction: characterization of crucial residues on the ligand and the receptor. EMBO J 1995; 14: 3395-3402.
38. Graber P, Proudfoot AE, Talabot F, Bernard A, McKinnon M, Banks M et al. Identification of key charged residues of human interleukin-5 in receptor binding and cellular activation. J Biol Chem 1995; 270: 15762-15769.
39. Tavernier J, Tuypens T, Verhee A, Plaetinck G, Devos R, Van der Heyden J et al. Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist. Proc Natl Acad Sci USA 1995; 92: 5194-5198.
40. Sanderson CJ, Urwin D. Interleukin-5: a drug target for allergic diseases. Curr Opin Investig Drugs 2000; 1: 435-441.
41. Lipscombe RJ, Nakhoul AM, Sanderson CJ, Coombe DR. Interleukin-5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix. J Leukoc Biol 1998; 63: 342-350.
42. Zabeau L, Van der Heyden J, Broekaert D, Verhee A, Vandekerckhove J, Wu SJ et al. Neutralizing monoclonal antibodies can potentiate IL-5 signaling. Eur J Immunol 2001; 31: 1087-1097.
43. Devos R, Guisez Y, Cornelis S, Verhee A, Van der Heyden J, Manneberg M et al. Recombinant soluble human interleukin-5 (hIL-5) receptor molecules. Cross-linking and stoichiometry of binding to IL-5. J Biol Chem 1993; 268: 6581-6587.
44. Carr PD, Gustin SE, Church AP, Murphy JM, Ford SC, Mann DA et al. Structure of the complete extracellular domain of the common beta subunit of the human GM-CSF, IL-3, and IL-5 receptors reveals a novel dimer configuration. Cell 2001; 104: 291-300.
45. Scibek JJ, Evergren E, Zahn S, Canziani GA, Van Ryk D, Chaiken IM. Biosensor analysis of dynamics of interleukin 5 receptor subunit beta(c) interaction with IL5:IL5R(alpha) complexes. Anal Biochem 2002; 307: 258-265.
46. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev 2004; 202: 175-190.
47. Moy FJ, Diblasio E, Wilhelm J, Powers R. Solution structure of human IL-13 and implication for receptor binding. J Mol Biol 2001; 310: 219-230.
48. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999; 17: 701-738.
49. Hilton DJ, Zhang JG, Metcalf D, Alexander WS, Nicola NA, Willson TA. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci USA 1996; 93: 497-501.
50. Mueller TD, Zhang JL, Sebald W, Duschl A. Structure, binding, and antagonists in the IL-4/IL-13 receptor system. Biochim Biophys Acta 2002; 1592: 237-250.
51. LaPorte SL, Juo ZS, Vaclavikova J, Colf LA, Qi X, Heller NM et al. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell 2008; 132: 259-272.
52. Jones CA, Williams KA, Finlay-Jones JJ, Hart PH. Interleukin 4 production by human amnion epithelial cells and regulation of its activity by glycosaminoglycan binding. Biol Reprod 1995; 52: 839-847.
53. Lortat-Jacob H, Garrone P, Banchereau J, Grimaud JA. Human interleukin 4 is a glycosaminoglycan-binding protein. Cytokine 1997; 9: 101-105.
54. den Dekker E, Grefte S, Huijs T, ten Dam GB, Versteeg EM, van den Berk LC et al. Monocyte cell surface glycosaminoglycans positively modulate IL-4-induced differentiation toward dendritic cells. J Immunol 2008; 180: 3680-3688.
55. Lutz MB, Schnare M, Menges M, Rossner S, Rollinghoff M, Schuler G et al. Differential functions of IL-4 receptor types I and II for dendritic cell maturation and IL-12 production and their dependency on GM-CSF. J Immunol 2002; 169: 3574-3580.
56. Ramsden L, Rider CC. Selective and differential binding of interleukin (IL)-1 alpha, IL-1 beta, IL-2 and IL-6 to glycosaminoglycans. Eur J Immunol 1992; 22: 3027-3031.
57. Najjam S, Gibbs RV, Gordon MY, Rider CC. Characterization of human recombinant interleukin 2 binding to heparin and heparan sulfate using an ELISA approach. Cytokine 1997; 9: 1013-1022.
58. Najjam S, Mulloy B, Theze J, Gordon M, Gibbs R, Rider CC. Further characterization of the binding of human recombinant interleukin 2 to heparin and identification of putative binding sites. Glycobiology 1998; 8: 509-516.
59. Gaffen SL. Signaling domains of the interleukin 2 receptor. Cytokine 2001; 14: 63-77.
60. Rickert M, Wang X, Boulanger MJ, Goriatcheva N, Garcia KC. The structure of interleukin-2 complexed with its alpha receptor. Science 2005; 308: 1477-1480.
61. Wang X, Rickert M, Garcia KC. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gamma c receptors. Science 2005; 310: 1159-1163.
62. ten Dam GB, Hafmans T, Veerkamp JH, van Kuppevelt TH. Differential expression of heparan sulfate domains in rat spleen. J Histochem Cytochem 2003; 51: 727-739.
63. Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 2003; 149: 1-38.
64. Mummery RS, Rider CC. Characterization of the heparin-binding properties of IL-6. J Immunol 2000; 165: 5671-5679.
65. Boulanger MJ, Chow DC, Brevnova EE, Garcia KC. Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex. Science 2003; 300: 2101-2104.
66. Barreda DR, Hanington PC, Belosevic M. Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol 2004; 28: 509-554.
67. Tamada T, Honjo E, Maeda Y, Okamoto T, Ishibashi M, Tokunaga M et al. Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex. Proc Natl Acad Sci USA 2006; 103: 3135-3140.
68. Liang A, He X, Du Y, Wang K, Fung Y, Lin B. Capillary zone electrophoresis investigation of the interaction between heparin and granulocyte-colony stimulating factor. Electrophoresis 2004; 25: 870-875.
69. Liang A, Chao Y, Liu X, Du Y, Wang K, Qian S et al. Separation, identification, and interaction of heparin oligosaccharides with granulocyte-colony stimulating factor using capillary electrophoresis and mass spectrometry. Electrophoresis 2005; 26: 3460-3467.
70. Liang A, Zhou X, Wang Q, Liu X, Qin J, Du Y et al. Interactions of dextran sulfates with granulocyte colony-stimulating factor and their effects on leukemia cells. Electrophoresis 2006; 27: 3195-3201.
71. Liang A, Zhou X, Wang Q, Liu X, Du Y, Wang K et al. Structural features in carrageenan that interact with a heparin-binding hematopoietic growth factor and modulate its biological activity. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 843: 114-119.
72. Osmond RI, Kett WC, Skett SE, Coombe DR. Protein-heparin interactions measured by BIAcore 2000 are affected by the method of heparin immobilization. Anal Biochem 2002; 310: 199-207.